WHAT'S NEW IN CPS
Check out our latest content updates
CPhA is thrilled to share with you the latest additions and updates in CPS.
Content updates
Major updates
The following content has been extensively updated and reviewed by 2 external peer reviewers:
- Fungal Skin Infections: New patient infographic.
- Drug-induced Skin Reactions: New information on skin reactions with DPP-4 inhibitors and EGFR inhibitors; added several new photos showing multiple skin tones and examples of Stevens-Johnson syndrome, toxic epidermic necrolysis, photosensitivity, and acute generalized exanthematous pustulosis; new patient infographic.
- HIV Infection: Treatment: Routine review; updated to align with current guidelines and Canadian clinical practice.
Minor updates
The following content has been reviewed to ensure that it is current:
- Drugs in Dentistry: Updated to reflect Choosing Wisely Canada and American Dental Association guidelines; updated options for patients with penicillin allergy.
- Gender-Affirming Care: Added a Resources section linking to CPhA’s Sexual and Reproductive Health Toolkit.
- Opioid Related Disorders: Updated to reflect CANMAT guidelines recommending that methadone and suboxone are both first-line options; added discussion of slow-release morphine (Kadian) as an off-label specialist-led option and added this product to the drug table.
Drug monographs
The following drug monograph was recently added:
- Neffy (epinephrine): Catecholamine / Sympathomimetic.

Check out what’s new in CPS to learn more.

